Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TROFOSFAMIDE vs TUCATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TROFOSFAMIDE vs TUCATINIB: Safety Overview

Metric TROFOSFAMIDE TUCATINIB
Total FAERS Reports 109 6,042
Deaths Reported 19 640
Death Rate 17.4% 10.6%
Hospitalizations 35 1,717
Average Patient Age 55.1 yrs 57.6 yrs
% Female Patients 36.5% 95.5%
FDA Approval Date N/A Apr 17, 2020
Manufacturer N/A SEAGEN INC.
Route N/A ORAL
Marketing Status N/A Prescription